Historical shareholding details of BlackRock Health Sciences Term Trust holdings in Halozyme Therapeutics Inc. (HALO)

Monthly changes of BlackRock Health Sciences Term Trust shareholding in Halozyme Therapeutics Inc. over the previous months

Month Name Total no. shares held Percent Holding
Dec 31, 2024 Blackrock Health Sciences Term Trust 171,850 0.14%
Sep 30, 2024 Blackrock Health Sciences Term Trust 171,850 0.14%
Aug 31, 2024 Blackrock Health Sciences Term Trust 164,360 0.13%
Jul 31, 2024 Blackrock Health Sciences Term Trust 164,360 0.13%
Jun 30, 2024 Blackrock Health Sciences Term Trust 158,200 0.12%
May 31, 2024 Blackrock Health Sciences Term Trust 158,200 0.12%
Apr 30, 2024 Blackrock Health Sciences Term Trust 158,300 0.12%
Mar 31, 2024 Blackrock Health Sciences Term Trust 158,300 0.12%
Feb 29, 2024 Blackrock Health Sciences Term Trust 158,300 0.12%
Jan 31, 2024 Blackrock Health Sciences Term Trust 158,300 0.12%
Dec 31, 2023 Blackrock Health Sciences Term Trust 158,300 0.12%
Nov 30, 2023 Blackrock Health Sciences Term Trust 158,300 0.12%
Oct 31, 2023 Blackrock Health Sciences Term Trust 158,300 0.12%
Sep 30, 2023 Blackrock Health Sciences Term Trust 158,300 0.12%
Aug 31, 2023 Blackrock Health Sciences Term Trust 158,300 0.12%
Jul 31, 2023 Blackrock Health Sciences Term Trust 224,005 0.17%
Jun 30, 2023 Blackrock Health Sciences Term Trust 224,005 0.17%
May 31, 2023 Blackrock Health Sciences Term Trust 224,005 0.17%
Apr 30, 2023 Blackrock Health Sciences Term Trust 224,005 0.17%

View all ownership details of Halozyme Therapeutics Inc.